The CXC receptor 2 is overexpressed in psoriatic epidermis

The Journal of Investigative Dermatology
Reinhard KulkeE Christophers

Abstract

The CXC chemokines interleukin-8 and GRO/melanoma growth-stimulatory activity (GRO-alpha) are potent activators of neutrophils and lymphocytes, but also stimulate growth and differentiation of nonhematopoietic cells like keratinocytes, fibroblasts, and melanocytes. High mRNA and protein levels have been detected in psoriatic epidermis. Chemokine activation of target cells is mediated by specific receptors and two CXC receptors have been described with similar affinity for interleukin-8 but different affinities for GRO-alpha. In this study, we examined the expression of both CXCR1 and CXCR2 in psoriatic tissue, identifying the target cells of chemokine activation in psoriasis. By immunohistochemistry and in situ hybridization, as confirmed by northern blot analysis and reverse transcriptase polymerase chain reaction, we could detect expression of the CXCR2 in suprabasal lesional psoriatic keratinocytes but not in healthy skin. The CXCR1 could not be localized in psoriatic keratinocytes with immunohistochemistry and in situ hybridization, but infiltrating cells in the dermal compartment expressed both types of receptors. These data suggest that in addition to neutrophil activation by both CXCR1 and CXCR2, activation of keratinocy...Continue Reading

References

Dec 11, 1992·Science·A E KochR M Strieter
Sep 1, 1992·The Journal of Investigative Dermatology·A TuschilI Lindley
Jan 1, 1991·The Journal of Investigative Dermatology·M SticherlingE Christophers
Feb 1, 1992·The Journal of Investigative Dermatology·J M SchröderE Christophers
Jul 1, 1986·The Journal of Investigative Dermatology·J M Schröder, E Christophers
Jun 1, 1993·Journal of Cutaneous Pathology·W TettelbachA Richmond
Nov 1, 1996·Nature Medicine·B A Premack, T J Schall
Jun 1, 1983·The Journal of Investigative Dermatology·J E FrakiG S Lazarus

❮ Previous
Next ❯

Citations

Jun 3, 2000·Annual Review of Immunology·D Rossi, A Zlotnik
Dec 5, 2002·The Journal of Clinical Investigation·John A BelperioRobert M Strieter
Sep 12, 2006·The Journal of Clinical Investigation·Christophe CataissonStuart H Yuspa
Nov 12, 2014·International Reviews of Immunology·Margherita Sisto, Sabrina Lisi
Sep 28, 2013·Expert Opinion on Therapeutic Targets·Tej Pratap SinghJoshua M Farber
Jul 2, 2005·Expert Opinion on Emerging Drugs·Robert Gniadecki, Martin J Calverley
Dec 20, 2011·Journal of Dermatological Science·Tomotaka MabuchiSam T Hwang
Aug 16, 2011·Pharmacology & Therapeutics·Pim J KoelinkAletta D Kraneveld
Nov 12, 2010·The Journal of Surgical Research·David F SchneiderDouglas E Faunce
Oct 16, 2004·The Journal of Investigative Dermatology·Carol L BarkerJames H Pringle
Jun 16, 2005·The Journal of Investigative Dermatology·Eunkyung ChungRobert J Coffey
Apr 5, 2001·The Journal of Investigative Dermatology·H PeteringJ Elsner
Jun 13, 2002·The Journal of Investigative Dermatology·Aimee S Payne, Lynn A Cornelius
Nov 17, 2001·The Journal of Investigative Dermatology·I SzaboT J Rogers
Aug 22, 2000·The Journal of Investigative Dermatology·R M DevalarajaA Richmond
Nov 24, 2007·The Journal of Investigative Dermatology·Tomoyasu HattoriTakashi Izumi
Aug 30, 2008·Clinics in Dermatology·Bernhard Homey, Stephan Meller
May 1, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Aldona T PietrzakJacek M Roliński
Dec 13, 2006·Cytokine·Frank R WetteyRoy Pettipher
Oct 20, 2004·The Journal of Dermatology·Yuichiro TsunemiKunihiko Tamaki
Aug 24, 2007·Clinical and Experimental Dermatology·P PaquetG E Piérard
Jul 6, 2012·Cytokine·Patricia Hartstein SalimRicardo Machado Xavier
Sep 23, 2014·Mathematical Biosciences·Lingjian YangSophia Tsoka
Aug 18, 2000·The Journal of Surgical Research·H O RennekampffJ M Schröder
May 18, 2016·The Journal of Investigative Dermatology·Ester Ruiz-RomeuLuis F Santamaria-Babí
Jul 13, 2000·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·A M KleinD Kreutzer
Oct 12, 2012·Neuroimmunomodulation·Andrea Cecilia ParradoEstela Beatriz Rey-Roldán
Nov 1, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Erika SuzukiIannis E Adamopoulos
Mar 29, 2005·World Journal of Gastroenterology : WJG·Hajime IsomotoShigeru Kohno
Mar 29, 2001·Nature Immunology·M P Schön, T Ruzicka
Feb 1, 2000·Journal of Cellular Physiology·S KondoK Jimbow
Aug 12, 2005·European Journal of Immunology·Katsuhiro MiharaWim Dokter
Apr 1, 2014·Expert Review of Clinical Immunology·Remo C RussoFlavio A Amaral
May 15, 2007·The Journal of Pharmacology and Experimental Therapeutics·Waldemar GonsiorekR William Hipkin
Feb 5, 2009·The Journal of Pharmacology and Experimental Therapeutics·Petra de KruijfRob Leurs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.